Home Cart Sign in  
Chemical Structure| 24697-74-3 Chemical Structure| 24697-74-3

Structure of Leonurine
CAS No.: 24697-74-3

Chemical Structure| 24697-74-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Leonurine is a pseudoalkaloid possessing anti-inflammatory properties and isolated from plants of family Lamiaceae.

Synonyms: SCM-198

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Leonurine

CAS No. :24697-74-3
Formula : C14H21N3O5
M.W : 311.33
SMILES Code : NC(NCCCCOC(C1=CC(OC)=C(O)C(OC)=C1)=O)=N
Synonyms :
SCM-198
MDL No. :MFCD09839432
InChI Key :WNGSUWLDMZFYNZ-UHFFFAOYSA-N
Pubchem ID :161464

Safety of Leonurine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
PC12 cells 50 μg/mL, 100 μg/mL, 200 μg/mL 2 hours To evaluate the protective effects of Leonurine against oxygen-glucose deprivation (OGD)-induced oxidative stress and apoptosis. Results showed that Leonurine significantly reduced ROS and MDA levels, increased SOD activity and GSH content, and decreased cell apoptosis. Int J Mol Sci. 2022 Sep 5;23(17):10188
293T cells 20 µM Leonurine treatment reduced the expression of TAZ Front Immunol. 2020 Oct 7;11:556526
ectopic endometrial stromal cells (eESCs) 200 µM 48 hours SCM-198 notably suppressed estrogen production in eESCs. Int J Biol Sci. 2022 Feb 21;18(5):1961-1973
CD4+CD25- T cells 200 µM 48 hours SCM-198 significantly reduced the expansion of Tregs induced by E2 or PPT and reversed the production of IL-10 and TGF-β1. Int J Biol Sci. 2022 Feb 21;18(5):1961-1973
Synovial fibroblast-like cells 10 µM and 20 µM Leonurine treatment reduced IL-6-induced expression of TAZ, RANKL, and RANK Front Immunol. 2020 Oct 7;11:556526
CD4+T lymphocytes 20 µM Leonurine treatment reversed the Treg/Th17 imbalance induced by TAZ Front Immunol. 2020 Oct 7;11:556526
Rat bone marrow-derived mesenchymal stem cells (BMSCs) 10 μM 4 hours Leonurine at 10 μM concentration can alleviate oxidative stress-induced apoptosis and promote the differentiation ability of rat BMSCs. Cells. 2022 May 24;11(11):1724
Primary cortical neurons 10 μM 24 h SCM-198 prevented neuronal apoptosis and protected the neurons against neurite breakage and LDH leakage induced by Aβ42 stimulation. Int J Mol Sci. 2015 Aug 7;16(8):18544-63
Primary cortical neurons 10 μM 2 h SCM-198 significantly inhibited the reductions in p-CREB, BDNF and p-TrkB expressions induced by Aβ42 exposure, which could be blocked by H89 or Rp-cAMPS treatment. Int J Mol Sci. 2015 Aug 7;16(8):18544-63

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Endometriosis model Intraperitoneal injection 7.5 mg/kg and 15 mg/kg Once daily for one week SCM-198 significantly suppressed the growth of ectopic lesions and downregulated the accumulation of Tregs and their cytokine production (IL-10 and TGF-β1). Int J Biol Sci. 2022 Feb 21;18(5):1961-1973
Sprague-Dawley rats Ovariectomy model (OVX) Intraperitoneal injection 15 mg/kg per day Once daily for 8 weeks Leonurine significantly alleviated osteoporosis progression and promoted bone healing in osteoporotic rats. Cells. 2022 May 24;11(11):1724
AβPP/PS1 double-transgenic mice Alzheimer’s disease model Oral 50 and 100 mg/kg Once daily for 3 months SCM-198 could significantly improve both recognition and spatial memory, inhibit microgliosis and promote neuronal survival in AβPP/PS1 double-transgenic mice without affecting amyloid-β (Aβ) burden. Int J Mol Sci. 2015 Aug 7;16(8):18544-63

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.21mL

0.64mL

0.32mL

16.06mL

3.21mL

1.61mL

32.12mL

6.42mL

3.21mL

References

 

Historical Records

Categories